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inflammatory cell infiltrates.10,11 Quantitative and phenotypic analyses 
of inflammatory infiltrates in testis reveal increased numbers of 
macrophages,12 dendritic cells,13 MC,14,15 and different T cell subsets 
including effector Th1 and Th17 cells and Foxp3+ regulatory T 
cells.11,16 Upregulation of chemokines and pro-inflammatory cytokines 
as well as nitric oxide (NO) is also involved in the impairment of 
spermatogenesis.17–19 EAO progression is associated with fibrosis, 
testicular atrophy, and infertility.
Testicular cord torsion (TCT) is an emergency affecting 1:4000 
males under 25 years old. Its incidence in general hospitals is between 
4 and 20 cases per year.20,21 Surgical detorsion is the only effective 
treatment to improve testicular function. However, these patients 
may develop infertility or subfertility in the future, even after surgical 
detorsion or orchiectomy, and nearly 10% of testicular biopsies for 
gamete criopreservation are secondary to this pathology.22,23 Other 
clinical studies have not confirmed these observations and argued 
that the fertility potential of these patients is normal.24 Our results 
demonstrated previously that TCT in rats induces tissue damage in the 
contralateral testis characterized by macrophage infiltrates associated 
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Ketotifen fumarate (KF), 4-(methyl-4-piperidylene)-4H-benzo[4,5]
cyclohepta[1,2-b]thiophen-10(9H)-one hydrogen fumarate, has been 
widely used as an anti-allergic and anti-anaphylactic agent in adults 
and children.1 It has been administered to prevent allergic asthma by 
blocking release of allergic mediators from mast cells (MC) and by 
antagonizing histamine H1 receptors.2 Significant improvement in 
semen parameters after KF treatment has been reported in patients 
with idiopathic oligozoospermia and asthenospermia or as therapy 
after varicocelectomy.3–5 Recently, Baba et al.6 demonstrated that KF 
dose-dependently inhibits the process of exocytosis of rat MC. In 
addition to exocytotic release of histamine, leukotrienes, and proteases, 
MC are also involved in the development of fibrosis in many organs 
including testis.7
Experimental autoimmune orchitis (EAO) is a useful model 
to study organ-specific autoimmunity and chronic testicular 
inflammation. The rodent model mimics pathological changes 
reported in immunological infertility in men.8,9 EAO is characterized 
by apoptosis and sloughing of germ cells and the presence of interstitial 
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with seminiferous tubules showing increased germ cell apoptosis. 
Significantly increased MC were also observed in this model.25
Although some publications describe the use of KF in male 
infertility, to our knowledge, no studies report the effect of MC blockers 
on EAO and TCT. Therefore, this study aimed to determine whether 




Adult male Wistar or Sprague–Dawley rats 45–60 days old were 
purchased from “Bioterio Central,” School of Pharmacy and 
Biochemistry, University of Buenos Aires (Buenos Aires, Argentina). 
Animals were kept at 22°C with a 14-h light/10-h dark schedule 
and fed standard food pellets and water ad libitum. Experiments 
were performed in accordance with the Guide for Care and Use 
of Laboratory Animals published by National Institutes of Health. 
Approval for the study protocol was obtained from the Use and Care 
of Experimental Animals Committee of School of Medicine, University 
of Buenos Aires.
Induction of EAO and histopathology
Wistar rats were actively immunized with testicular homogenate 
(TH) prepared as previously described.26 Briefly, the rat testes were 
decapsulated, diluted in an equal volume of saline, and disrupted 
in an Omni mixer (17105 OM, Sorvall, Norwalk, CT, USA) for 30 
s. The final concentration was 500 mg ml−1 wet weight. The rats 
were injected three times with 200 mg wet weight of TH per dose 
per rat at 14-day intervals. TH (0.4 ml) emulsified with 0.4 ml 
complete Freund’s adjuvant (Sigma-Aldrich, St. Louis, MO, USA) 
was injected into footpads and subcutaneously at multiple sites in 
flanks and the neck area. The first two immunizations were followed 
by an intravenous injection of 0.5 ml Bordetella pertussis (Bp) (strain 
10536, “Instituto Malbrán,” Buenos Aires, Argentina) containing 
1010 microorganisms and the third by intraperitoneal injection of 
5 × 109 microorganisms. The rats were killed 56 days after the first 
immunization. Testes and epididymis were removed, weighed, and 
studied in paraffin-embedded Bouin’s (Sigma-Aldrich)-fixed sections 
obtained from three different levels and stained with hematoxylin-eosin 
Y (yellowish; Merck, Darmstadt, Germany). To evaluate the degree of 
germ cell damage characteristic of EAO, we used a score described 
previously.12 Briefly, this score includes (a) percentage of damaged 
seminiferous tubules (ST), (b) degree of germ cell sloughing, and (c) 
testicular/body weight ratio (T/Bw). Therefore, EAO score = V + T 
+ P, where V is the value assigned to the percentage of damaged ST 
(presenting germ cell sloughing and degeneration); V = 0 (0%–3% 
damaged ST); 1 (3.1%–4.9%); 2 (5%–15.9%); 3 (16%–25.9%); 4 
(26%–35.9%); 5 (36%–55.9%); 6 (56%–60.9%); 7 (61%–79.9%); 8 
(80%–95.9%); or 9 (96%–100%). T is an indicator of degree of germ 
cell sloughing: T = 0 when mild germ cell sloughing is observed and 
T = 0.5 when germ sloughing is severe (only spermatogonia and 
Sertoli cells are still attached to the ST walls). P is a correction factor 
corresponding to the T/Bw index: P = 0.5 when T/Bw index is <2.5 
× 103. The rats with a score over 0 were considered to have orchitis.
Induction of TCT and histopathology
Under anesthesia, a scrototomy on the left side and a 720° unilateral 
spermatic cord torsion was performed on Sprague–Dawley rats in the 
experimental (E) group. The testis was fixed into the scrotum using 4-0 
silk suture. The rats were killed 30 days after surgery. At the end of each 
time segment, the contralateral testis was removed, weighed, fixed in 
Bouin’s solution, dehydrated, and embedded in paraffin or quickly frozen 
to obtain cryostat sections for histopathology or immunohistochemistry, 
respectively. Paraffin-embedded testis sections (6 μm) were stained with 
hematoxylin-eosin Y. Tubular damage was quantified by a modified 
Johnsen score, which analyzes the degree of damage to seminiferous 
tubule germ cells by a score from 1 to 10.25 Complete spermatogenesis 
with many spermatozoa is considered 10 and animals with a score under 
9 were considered to have testicular damage. The mean tubular score 
was obtained by evaluating 50 ST per testis per rat. Tubular diameter 
was calculated in transversal testis sections with the aid of an ocular 
micrometer (8×, Kpl, Zeiss, Oberkochen, Germany).
Experimental design
In EAO model, a group of immunized rats was injected intraperitoneally 
with 1 or 4 mg kg−1 of KF (Roma Pharmacy and Laboratory S.A., 
Buenos Aires, Argentina) or vehicle (saline solution) once daily. 
Treatment started 48 h before the first immunization and continued 
daily throughout the experiment (treatment 1). The treatment of 
another group of rats was started 7 days after the last immunization 
(treatment 2). In TCT model, the rats were injected intraperitoneally 
with KF (1 mg kg−1) or vehicle once a day. Treatment was started 
from the moment of the surgical procedure and continued daily 
throughout the experiment. The rationale for the doses of KF used in 
this experimental design was based on prior in vivo study using similar 
doses of KF and the maximum recommended dose.27
Histochemistry
To identify MC, testis sections were stained with Alcian blue 
(Sigma-Aldrich). MC were counted using a 25× objective, and the 
ocular (12.5×; 473014-9901, Zeiss, Oberkochen, Germany) was fitted 
with a quadratic grid with a total area of 96 100 μm2.
Delayed-type hypersensitivity (DTH)
DTH was measured by a footpad swelling test performed at the end of 
each experiment. The rats were intradermically challenged in the left 
footpad with 2.10 mg of TH supernatant in 50 μl saline. This fraction 
was obtained by TH centrifugation (PR-2 International Equipment Co., 
Boston, MA, USA) (20 000 g at 4°C). The other footpad was injected 
with the same volume of saline. Footpad thickness was measured with a 
micrometer (Teclock Corporation, Naruta-cho Okaya-shi NaganoPref., 
Japan) 48 h after the challenge. The results of footpad swelling were 
expressed as mean of at least three measurements per rat (in mm), 
calculated as the difference between the thickness of the HT-injected 
footpad and that of the saline injected footpad.
Statistical analyses
Comparisons of groups were assessed by the nonparametric 
Mann–Whitney U test or one-way ANOVA Kruskal–Wallis test as 
indicated in each figure’s legend. P ≤ 0.05 was considered statistically 
significant.
RESULTS
Administration of KF reduced severity of EAO and epididymitis
We evaluated the effects of KF administration on rats during EAO. 
Two experimental designs were used. In treatment 1, KF was 
administered before the first immunization; in treatment 2, KF was 
administered after the last immunization when the first signs of disease 
became apparent28,29 and continued until euthanasia. Histopathology 
showed that 100% of rats in the vehicle group developed orchitis 
(Figure 1a and 1b). In contrast, a decrease in EAO incidence 
and severity was observed in rats injected with KF (4 mg kg−1) in 
treatment 1 (80%) (Figure 1a). Interestingly, we also found that KF 
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significantly reduced severity of epididymis inflammation compared 
to the vehicle group (Figure 2). Rats in the vehicle group presented 
severe orchitis with large areas of aspermatogenic ST, in which only 
spermatogonia and Sertoli cells attached to the tubular wall and 
interstitial inflammatory cell infiltrates intermingled with Leydig cells 
were present (Figure 1c). In contrast, most rats (90%) treated with KF 
showed ST with scarce germ cell sloughing or normal seminiferous 
epithelium (Figure 1d). Body weight of KF (4 mg kg−1)-treated rats 
did not differ from that of untreated normal rats, suggesting that KF 
treatment induced no apparent adverse effects (P = 0.20) (mean ± 
standard error of the mean [s.e.m.] of body weight: untreated normal 
rats [n = 17], 342.90 ± 8.14 g; treatment 1 [n = 10], 336.50 ± 10.90 g; 
and treatment 2 [n = 6], 341.60 ± 14.90 g). Moreover, all rats survived 
after KF treatment. A significant reduction of inflammation and 
damage of ST was observed in KF treatment 1. In KF treatment 2, 
histopathology was similar in the vehicle and KF groups.
KF did not alter cell mediated immunity in vivo
We next investigated the effects of KF on T cell mediated immunity 
by analyzing in vivo DTH response to spermatic antigens. Footpad 
swelling observed in rats with treatment 1 (Figure 3a) and 2 (Figure 3b) 
was similar to that in rats treated with KF compared to those of vehicle 
groups.
KF treatment reduced MC numbers
To evaluate the effect of KF on testicular MC, sections from rats 
treated or untreated with KF were processed by Alcian blue staining. 
Figure 4a–4d illustrates the presence of MC near tunica albuginea. 
Quantitative assessment of Alcian blue-positive cells revealed that 
administration of KF to rats undergoing orchitis reduced the number 
of MC compared to vehicle-treated rats (P = 0.020; Figure 4e).
Administration of KF prevented histological damage in the 
contralateral testis after prolonged TCT
Multifocal damage of the contralateral testis was observed 30 days after 
testicular torsion in the vehicle group. Testis damage was characterized by 
sloughing of the germinal epithelium, seminiferous tubule atrophy, and 
interstitial edema. Focal signs of inflammation and fibrosis of seminiferous 
tubular walls were also observed (Figure 5a). In contrast, contralateral 
testis sections of rats treated with KF for 30 days after surgical torsion 
showed normal histology (Figure 5b). Comparison of tubular diameter 
and Johnsen score showed significant differences between KF and vehicle 
group (P = 0.003 and P = 0.008, respectively; Figure 5c and 5d).
KF reduced the number of MC in the contralateral testis after 
prolonged TCT
MC were observed near the tunica albuginea and vessels 
(Figure 6a–6d). The number of MC decreased significantly in the 
Figure 3: Ketotifen fumarate does not induce changes in cell mediated 
immunity in vivo. Rats with EAO treated with saline (vehicle) or ketotifen 
fumarate were tested for DTH to testicular antigens during (a) treatment 1 
and (b) treatment 2. Two days before euthanasia (day 54), TH was injected 
into rats’ left footpad. The right footpad was injected with saline. Footpad 
swelling was measured after 48 h and results are expressed as the mean 
difference between the thickness of the HT-injected footpad and that of the 
saline-injected footpad ± standard error of the mean (s.e.m.) in each group 
(nonparametric one-way ANOVA Kruskal–Wallis test). EAO: experimental 
autoimmune orchitis; DTH: delayed-type hypersensitivity.
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Figure 1: Impact of ketotifen fumarate on incidence and severity of EAO 
score. All rats were immunized with testicular homogenate and adjuvants. A 
group of rats was injected with saline solution (vehicle) or ketotifen fumarate. 
(a) Treatment 1. Administration of ketotifen fumarate (4 mg kg−1) reduced 
the severity of orchitis. (b) Treatment 2. Similar EAO scores were observed 
in the two groups studied. Horizontal lines represent the mean. Each symbol 
represents a single rat. Values with different symbols superscript (#, &) differ 
significantly P < 0.05 (nonparametric one-way ANOVA Kruskal–Wallis test). 
(c) Testis section from vehicle group rats killed 56 days after the first 
immunization showing severe testicular damage characterized by germ cell 
sloughing of seminiferous tubules and interstitial inflammatory cell infiltrate. 
Note severe tubular atrophy showing decreased diameter of seminiferous 
tubules in vehicle rats. (d) In contrast, testis section from rats treated with 
ketotifen fumarate (4 mg kg−1) shows normal histological features. Scale 
bars = 100 μm. EAO: experimental autoimmune orchitis.
dc
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Figure 2: Impact of ketotifen fumarate on epididymis. (a) Epididymal 
pathology of rats immunized with testicular homogenate and adjuvants 
and injected with saline solution (vehicle) or ketotifen fumarate. 
Treatment 1. Administration of ketotifen fumarate (4 mg kg−1) reduces 
severity of epididimytis. Horizontal lines represent the mean. Each symbol 
represents a single rat. Values with different symbols superscript (#, &) 
differ significantly P < 0.05 (nonparametric one-way ANOVA Kruskal–
Wallis test). (b) Epididymis section from vehicle group rats killed 56 
days after the first immunization showing a severe inflammatory cell 
infiltrates. (c) In contrast, epididymis section from rats treated with 
ketotifen fumarate (4 mg kg−1) shows moderate interstitial inflammation. 
Scale bars = 100 μm.
cb
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Figure 4: Administration of KF reduced mast cell number in EAO. 
Representative microphotographs of Alcian blue staining performed on 
EAO testis sections. Mast cells are observed near the tunica albuginea and 
vessels of both, (a and b) untreated or (c and d) treated with KF rats. Scale 
bars = 50  μm in a and c; and 20 μm in b and d. (e) Quantitative assessment 
of Alcian blue-positive mast cell number in EAO testis sections from 
rats treated with KF (treatment 1) or saline solution (vehicle). Horizontal 
lines represent the mean value and each symbol represents a single rat. 
P = 0.020 (Mann–Whitney U test). EAO: experimental autoimmune orchitis; 




Figure 5: Impact of KF in testicular damage after prolonged testicular cord 
torsion. Testicular histopathology. Representative microphotographs of 
sections of contralateral testis from rats (a) untreated or (b) treated with KF. 
Germ cell sloughing and seminiferous tubule atrophy in an untreated rat. 
Normal histology in a rat treated with KF. Scale bars = 100 μm. Quantitative 
assessment of tubular damage shows that (c) the mean tubular diameter 
and (d) Johnsen score are higher in KF versus vehicle group (P = 0.003 and 
P = 0.008, respectively). Horizontal lines represent the mean. Each symbol 
represents a single rat. (Mann–Whitney U test). KF: ketotifen fumarate.
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Figure 6: Administration of KF reduced mast cell number in testicular 
cord torsion model. Representative microphotographs of contralateral 
testis sections showing mast cells stained with Alcian blue. Mast cells are 
observed near the tunica albuginea and vessels of both, (a and b) untreated 
or (c and d) treated with KF rats. Scale bars = 50  μm in a and c; and 20 μm 
in b and d. (e) Quantitative assessment of Alcian blue-positive mast cell 
number in contralateral testis sections from rats treated with KF or saline 
solution (vehicle). P = 0.019. Horizontal lines represent the mean. Each 




contralateral testis of rats treated with KF compared to vehicle group 
(P = 0.019; Figure 6e).
DISCUSSION
Inflammatory processes in the testis are frequently associated with 
infertility.9 In fact, a high percentage of patients with subfertility or 
infertility present different degrees of testicular immune cell infiltrates.30
TCT and EAO are interesting models to study testicular 
inflammation and infertility. Testicular inflammatory infiltrates are 
composed mainly of dendritic cells, macrophages, lymphocytes, and 
MC.12,16,25 The inflammatory process and oxidative stress generate 
germ cell sloughing and apoptosis, resulting in aspermatogenesis and 
atrophy of ST.19,31
MC have a key role in inflammation and tissue fibrosis in several 
models of autoimmune diseases.32,33 In vitro, MC can promote fibroblast 
proliferation and collagen synthesis.34 Presynthesized substances 
such as histamine, chymase, tryptase, carboxipeptidase A, and tumor 
necrosis factor-alpha (TNFα) are stored in granules and released 
immediately after MC activation. TNFα, interleukin (IL) 6, and IL1b 
are de novo synthesized after MC activation.35 Because the present work 
focuses on MC, we evaluated the effect of KF, a high affinity blocker of 
histamine H1 receptor, on testicular inflammation and spermatogenesis 
in TCT and EAO experimental models.
Although a small number of MC are present in the normal mammal 
testis, in inflammatory conditions, the number of MC increases.35–37 
Testicular MC are also associated with sclerosis and fibrosis of ST in 
patients with varicocele and defective spermatogenesis.38,39
In the TCT model, multifocal damage of the contralateral 
testis characterized by focal signs of inflammation and fibrosis of 
seminiferous tubular walls was observed 30 days after testicular 
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torsion in the vehicle group. In contrast, the present results showed 
normal testicular histology in rats treated with 1 mg kg−1 day−1 of KF 
and a significantly decreased number of MC in the contralateral testis 
of rats treated with KF compared to the vehicle group. Similar to our 
findings, Acikgoz et al.27 observed that the number of MC decreased 
in the contralateral descended testis in rats treated with MC blocker in 
experimental unilateral undescended testis, supporting its therapeutic 
use for autoimmune testicular inflammation.
In the EAO model, we also observed decreased incidence and 
severity of orchitis and epididymal inflammation in rats injected 
with 4 mg kg−1 day−1 of KF compared to the vehicle. We observed no 
adverse effects on weight or behavior in rats treated with KF in spite of 
the high doses used. By analyzing in vivo DTH response to spermatic 
antigens, we showed that KF treatment does not modify cell mediated 
immunity. In effect, this drug is mainly an immunomodulator with 
anti-histaminic action but does not block molecular steps that activate 
cell-mediated immunity.
Reduction of the number of MC is associated with reduction of 
testicular damage and improved spermatogenesis. The results suggest 
that KF inhibits testicular MC degranulation preventing the release 
of inflammatory and fibrotic mediators, consequently improving 
histopathological parameters. MC are a source of numerous cytokines, 
chemokines, and growth factors with potential autocrine, paracrine, 
local, and systemic effects.40 In fact, some of these, such as TNFα, 
IL6, C-C chemokine ligand (CCL) 2, and CCL4, play a relevant role 
in the testis during inflammation.17 KF, like other MC stabilizers, was 
reported to restrain serum TNFα levels and improve survival in a 
murine experimental model of sepsis.41
KF also has a very important role in regulating macrophage 
metabolic activity, modulating nitric oxide (NO) production by 
inhibition of inducible oxide nitric synthase (iNOS) expression in 
lipopolysaccharide-stimulated cells. This inhibition is followed by 
a significant reduction in nitrite levels. This drug had no scavenger 
activity against NO in the chemical system. Therefore, it is possible 
that the inhibitory effect on macrophage iNOS expression could be 
due to its ability to affect intracellular signaling pathways leading NO 
production.42
MC act in concert with macrophages and Leydig cells, germ 
cells, and peritubular cells which also express histamine receptor 
H1.43,44 Histamine has also been reported to have an important role 
in controlling Leydig cell steroidogenesis.44 Hence, we cannot exclude 
the possibility that KF as an antagonist of H1 may modulate other 
parameters beyond those we describe in this report.
MC blockers have been used empirically for the treatment of 
male infertility with controversial results. Yamamoto et al.45 reported 
a significant improvement of semen parameters and pregnancies in a 
group of oligozoospermic patients treated with tranilast, and Matsuki 
et al.46 reported similar results in infertile male patients treated with the 
MC blocker ebastine. However, Cayan et al.47 reported that treatment 
with an antihistamine drug, fexofenadine, in infertile patients with a 
significant increase of testicular MC appears to have no benefit; no 
data concerning semen quality and pregnancies were reported. Use of 
this drug was discontinued due to lack of homogeneous results from 
different authors. Recently, Mondillo et al.48 summarized the negative 
impact of anti-histamines loratadine, desloratadine, cimetidine, and 
ranitidine on male reproduction.
In contrast, several authors reported that KF treatment of infertile 
patients with idiopathic oligozoospermia and asthenozoospermia 
resulted in moderate, but statistically significant improvement in 
sperm count and motility and reduction of leukocytospermia and 
necrospermia.3,5,49 Finally, in a preliminary study, we observed a 
significant improvement in seminal parameters and pregnancy rates 
after intracytoplasmic sperm injection (ICSI) in male patients with 
severe oligo-asthenozoospermia treated with KF.50
CONCLUSION
Our results indicate that MC are involved in the pathogenesis of 
testicular inflammatory process. We demonstrated that treatment with 
KF can significantly reduce testis damage in experimental models of 
orchitis and prevent impairment of contralateral testis after testicular 
torsion. The present work enlarges the use of KF as treatment in 
testicular pathologies associated with inflammation and germ cell loss.
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